Breaking News English

Paragraph 1

Help is at billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision for people whose billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision is worsening. An American billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision company called Allergan has developed eye drops that can treat an eye billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision called presbyopia. This is when people's close-up vision starts getting billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision. It usually starts when people get into their 40s. It affects over a billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision people around the globe. About 16 per cent of these cannot afford eyeglasses or access to eye billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision. The new eye drops are called Vuity. Allergan called them "an billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision new prescription eye drop". It said Vuity is "the billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision and only FDA-approved eye drop to treat age-related Blurry Near Vision (presbyopia) in adults". It added they "may help billionblurredconditionfirsthandinnovativepatientspharmaceuticalsurgeryvision with presbyopia see up close".